Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose safety, PK and PD study of SCH 900389 in healthy women
NL-OMON36461Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of SCH 900389 in infertility, sponsored by Merck & Co. Primary endpoints: Safety and tolerability after multiple oral doses and Pharmacodynamic effects after multiple oral doses. Started Mar 2011; status: active, not recruiting.
02
Drugs
SCH 900389
03
Conditions
infertility
Beyond the preview
Go deeper on NL-OMON36461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36461.